HomeAUPH • NASDAQ
add
Aurinia Pharmaceuticals Inc
Previous close
$13.97
Day range
$13.52 - $14.23
Year range
$6.83 - $16.54
Market cap
1.87B USD
Avg Volume
897.69K
P/E ratio
25.26
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 77.11M | 28.81% |
Operating expense | — | — |
Net income | 210.79M | 14,651.15% |
Net profit margin | — | — |
Earnings per share | 1.53 | 15,200.00% |
EBITDA | — | — |
Effective tax rate | -490.62% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | — | — |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 581.33M | — |
Shares outstanding | 132.97M | — |
Price to book | 3.18 | — |
Return on assets | — | — |
Return on capital | 15.11% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 210.79M | 14,651.15% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | 7.02M | -84.83% |
Free cash flow | — | — |
About
Founded
2012
Headquarters
Website
Employees
130
